Literature DB >> 12181418

Development of a real-time in vivo transcription assay: application reveals pregnane X receptor-mediated induction of CYP3A4 by cancer chemotherapeutic agents.

Erin Schuetz1, Lubin Lan, Kazuto Yasuda, Richard Kim, Thomas A Kocarek, John Schuetz, Stephen Strom.   

Abstract

We report the development of a rapid real-time assay that measures the transcription of luciferase reporter genes in transduced mouse hepatic cells in vivo. Luciferase activity is noninvasively measured by whole-body optical imaging within hours of the hydrodynamic injection of as little as 1 microg of naked DNA. Transcription of genes introduced as linearized DNA can be serially assayed for weeks in each animal. Transcription was quantified by extracorporal monitoring of bioluminescence as well as or better than by traditional in vitro bioluminescence assay. Our assay allows the measurement of transcription as it occurs, under the most informative biological conditions (i.e., in a living, intact organ). Furthermore, it substantially reduces the cost, time, and number of animals required for analysis of gene expression. The utility of the method is demonstrated in the discovery that topotecan and etoposide are ligands of pregnane X receptor that induce CYP3A4 transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181418     DOI: 10.1124/mol.62.3.439

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Camptothecin attenuates cytochrome P450 3A4 induction by blocking the activation of human pregnane X receptor.

Authors:  Yakun Chen; Yong Tang; Gregory T Robbins; Daotai Nie
Journal:  J Pharmacol Exp Ther       Date:  2010-05-26       Impact factor: 4.030

2.  Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.

Authors:  Edith J Mensah-Osman; Dafydd G Thomas; Michelle M Tabb; Jose M Larios; Dennis P Hughes; Thomas J Giordano; Michelle L Lizyness; James M Rae; Bruce Blumberg; Paul F Hollenberg; Laurence H Baker
Journal:  Cancer       Date:  2007-03-01       Impact factor: 6.860

Review 3.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

Review 4.  Hydrodynamic gene delivery and its applications in pharmaceutical research.

Authors:  Barbara Bonamassa; Li Hai; Dexi Liu
Journal:  Pharm Res       Date:  2010-12-30       Impact factor: 4.200

5.  Safety and tolerability of the poly(ADP-ribose) polymerase (PARP) inhibitor, olaparib (AZD2281) in combination with topotecan for the treatment of patients with advanced solid tumors: a phase I study.

Authors:  Jens Samol; Malcolm Ranson; Edwina Scott; Euan Macpherson; James Carmichael; Anne Thomas; James Cassidy
Journal:  Invest New Drugs       Date:  2011-05-18       Impact factor: 3.850

Review 6.  Nonviral gene transfer as a tool for studying transcription regulation of xenobiotic metabolizing enzymes.

Authors:  Barbara Bonamassa; Dexi Liu
Journal:  Adv Drug Deliv Rev       Date:  2010-08-14       Impact factor: 15.470

7.  In Vivo Imaging of Human MDR1 Transcription in the Brain and Spine of MDR1-Luciferase Reporter Mice.

Authors:  Kazuto Yasuda; Cynthia Cline; Yvonne S Lin; Rachel Scheib; Samit Ganguly; Ranjit K Thirumaran; Amarjit Chaudhry; Richard B Kim; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2015-08-17       Impact factor: 3.922

8.  Piperine activates human pregnane X receptor to induce the expression of cytochrome P450 3A4 and multidrug resistance protein 1.

Authors:  Yue-Ming Wang; Wenwei Lin; Sergio C Chai; Jing Wu; Su Sien Ong; Erin G Schuetz; Taosheng Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

Review 9.  Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines.

Authors:  Thomas K H Chang
Journal:  AAPS J       Date:  2009-08-18       Impact factor: 4.009

10.  Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations.

Authors:  Ashley J Mulford; Claudia Wing; M Eileen Dolan; Heather E Wheeler
Journal:  Hum Mol Genet       Date:  2021-04-26       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.